Evidence map›Paper›PMID 37514956›Full record

ArticleVaccines2023

Active Medical Learner Engagement Results in the Discovery That One Size Does Not Fit All in Overcoming COVID-19 Vaccine Hesitancy.

Arash Salari, Manpreet K Singh, Shuja Ayouby, Sanmisola George, Kimngan Nguyen, Guillermo Daniel Peverini, Nicolette Lam, Timothy Allison-Aipa, Susanna Zamarripa, Shunling Tsang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Arash SalariDepartment of Family Medicine, Riverside University Health System, Moreno Valley, CA 92555, USA.
Manpreet K SinghRiverside School of Medicine, University of California, Riverside, CA 92507, USA.
Shuja AyoubyDepartment of Family Medicine, Riverside University Health System, Moreno Valley, CA 92555, USA.
Sanmisola GeorgeDepartment of Family Medicine, Riverside University Health System, Moreno Valley, CA 92555, USA.
Kimngan NguyenDepartment of Family Medicine, Riverside University Health System, Moreno Valley, CA 92555, USA.
Guillermo Daniel PeveriniComparative Effectiveness and Clinical Outcomes Research Center, Riverside University Health System, Moreno Valley, CA 92555, USA.
Nicolette LamComparative Effectiveness and Clinical Outcomes Research Center, Riverside University Health System, Moreno Valley, CA 92555, USA.
Timothy Allison-AipaComparative Effectiveness and Clinical Outcomes Research Center, Riverside University Health System, Moreno Valley, CA 92555, USA.ORCID 0000-0001-8169-7804
Susanna ZamarripaComparative Effectiveness and Clinical Outcomes Research Center, Riverside University Health System, Moreno Valley, CA 92555, USA.
Shunling TsangDepartment of Family Medicine, Riverside University Health System, Moreno Valley, CA 92555, USA.
Anthony FirekComparative Effectiveness and Clinical Outcomes Research Center, Riverside University Health System, Moreno Valley, CA 92555, USA.ORCID 0000-0001-6649-2798
Riverside University Health System - Medical Center · USUniversity of California, Riverside · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccine hesitancy is an ongoing public health concern defined as the refusal of a vaccine that is readily available. Therefore, we developed a project to explore why patients in a safety net medical center were hesitant or refused the COVID-19 vaccine. The project was conducted by healthcare learners to promote "learning by doing". Responses were collected through a previously developed and ongoing survey among both hospitalized and ambulatory patients that had no previous history of COVID-19 infection, were currently infected, or had recovered from COVID-19. Results were analyzed using a priori power analysis and Chi-squared test. We discovered that different self-reported ethnic groups had different reasons for vaccine hesitancy; specifically, 69% of Black/African American respondents stated that their main reason for hesitancy was vaccine safety compared to 13.9% of non-Hispanic Whites (

Indexed as

COVID-19determinantspatientsraceSARS-CoV-2vaccine acceptancevaccine hesitancy

Identifiers

PMID37514956
PMCPMC10385578
OpenAlexW4382064211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.